Treatment Rationale: A specific type of beta-glucan molecule, beta-1,3-1,6-glucan has the molecular activity to increase the anti-cancer activity of vitally important types of immune cells.

Treatment Rationale: Curcumin is a natural product supplement molecule derived from the turmeric root commonly used in cooking. The curcumin molecule has multiple anti-cancer effects against multiple molecular targets in cancer cells and other cancer-supporting cells. Curcumin molecules are poorly absorbed by the body unless processed to make them more easily absorbed by the intestinal tract. Boiling curcumin molecules for at least 12-15 minutes causes a significant amount of curcumin molecules to dissolve in water to significantly increase absorbability by drinking.

Treatment Rationale: The molecule EGCG (epigallocatechin gallate) and several related molecules contained in green tea standardized extracts possess significant anti-cancer molecular effects against multiple molecular targets in numerous types of cancer cells.

Treatment Rationale: To replace vitamin B-12 lost from administration of re-purposed anti-cancer (off-label) prescription Metformin.

Treatment Rationale: Metformin is a common generic drug widely prescribed for management of blood sugar in Type 2 diabetes.   Metformin also has anti-cancer molecular activity in numerous cancer cell types by effecting multiple molecular targets.   Metformin’s most-well documented anti-cancer molecular activity is to activate the molecular activity of AMPK.   In addition, Metformin possesses anti-cancer molecular activity against cancer stem cells and demonstrates synergistic anti-cancer activity with radiation therapy and specific chemotherapy agents.

Treatment Rationale: Celecoxib is an NSAID medication that inhibits the COX-2 molecular target in cells – including in cancer cells.

Celecoxib has anti-cancer molecular activity against the COX-2 molecular target in multiple cancer cell types. In addition, Celecoxib exerts anti-cancer molecular effects against multiple other molecular targets in cancer cells and cancer supporting cells. Celecoxib also demonstrates synergistic anti-cancer molecular activity with various specific natural health product (NHP) supplements, chemotherapy agents, targeted biologic agents, other re-purposed pharmaceuticals, and radiation therapy in various cancer cell types.